This research identifies streptolancidin D's role in promoting competitive advantages in Streptococcus pneumoniae, indicating its regulation by the Rgg 144/SHP 144 quorum-sensing system.
Streptococcus pneumoniae is a major colonizer of the human nasopharynx, where inter- and intra-strain competition plays a critical role in shaping population structure and influencing vaccine outcomes. Bacteriocins are key mediators of intra-species competition, yet many of their functions and regulatory mechanisms remain poorly understood. Here, we identify and characterize streptolancidin D, a previously uncharacterized bacteriocin encoded by the sldA-T locus and demonstrate its contribution to pneumococcal competition. Using a naturally colonizing strain, we show that deletion of sldA-T impairs inhibition of competitor strains in in vitro biofilms and during murine co-colonization. We further show that sldA-T is regulated by the Rgg 144 /SHP 144 quorum sensing system, with promoter activity abolished in a SHP-deficient background and partially restored by exogenous peptide stimulation. Genomic analyses revealed that sldA-T is consistently encoded downstream of the Rgg 144 /SHP 144 system and is present in ~12% of over 7,500 pneumococcal genomes, with lineage-specific patterns of distribution. This observation suggests a regulated mechanism that provides competitive advantages in strain–strain interactions, which might help explaining the long-term persistence of certain clones even under PCV13 pressure. Our findings uncover a previously unrecognized quorum sensing-regulated antimicrobial system in S. pneumoniae that enhances strain competitiveness and may contribute to lineage persistence and replacement dynamics under selective pressures such as vaccination.
No takes yet. Share an insight, caveat, or question.
Valente et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: